← Back to Clinical Trials
Recruiting NCT06501079

Dexamethasone Versus Mg Added to Bupivacaine Used in ESPB for Perioperative Pain Control in Patients Undergoing Unilateral Nephrectomy

Trial Parameters

Condition Renal Neoplasm
Sponsor National Cancer Institute, Egypt
Study Type INTERVENTIONAL
Phase N/A
Enrollment 78
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2024-05-01
Completion 2024-11-01
Interventions
ultrasound guided Erector Spinae Plane Block using 27ml bupivacaine 0.25%

Brief Summary

Aim of the study: The current study aims to compare the effect of adding dexamethasone versus magnesium sulfate to bupivacaine in ultrasound-guided erector spinae plane block on the severity of postoperative pain. Primary Objectives: \- To compare the effect of ESPB without additives to the effect of adding dexamethasone and to the impact of adding magnesium sulfate in the form of post-operative morphine consumption

Eligibility Criteria

Inclusion Criteria: * Adult (18 - 65) * Patients undergoing unilateral nephrectomy * ASA II / III Exclusion Criteria: * Patient refusal * Age less than 18 years * Allergy to any of the studied medications * Mid line incision * Bilateral nephrectomy * Distorted anatomy of the back (e.g. kyphoscoliosis) * Known neurologic disorders, psychiatric disorder or chronic pain * Local infection * Hemodynamic instability

Related Trials